- €33.06m
- €93.86m
- €218.97m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 170 | 191 | 203 | 248 | 219 |
Cost of Revenue | |||||
Gross Profit | 167 | 186 | 197 | 238 | 209 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 162 | 185 | 192 | 237 | 215 |
Operating Profit | 8.02 | 5.57 | 11.8 | 10.6 | 4.03 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.74 | 4.01 | 10.3 | 9.13 | 1.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.65 | 3.19 | 8.08 | 7.47 | 1.03 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4.54 | 2.68 | 7.6 | 7.16 | 0.645 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.54 | 2.68 | 7.6 | 7.16 | 0.645 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.235 | 0.124 | 0.308 | 0.273 | 0.028 |
Dividends per Share |